SCHEMBL17845654

SCHEMBL17845654

Cc1nnc(-n2c(=O)[nH]c3ccc(S(N)(=O)=O)c(C4(CF)CC4)c32)s1

nearest known ligand 0.45

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 20/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28533960 0.81 PARG (0.51) PARG
SCHEMBL17825358 0.76 PARG (0.53) PARG
SCHEMBL28531567 0.75 PARG (0.57) PARG
SCHEMBL31122095 0.71 PARG (0.53) PARG
SCHEMBL31122018 0.67 PARG (0.76) PARG
SCHEMBL31122017 0.67 PARG (0.76) PARG
SCHEMBL28536670 0.65 PARG (0.54) PARG
SCHEMBL17825247 0.64 PARG (0.53) PARG
SCHEMBL28531839 0.64 PARG (0.51) PARG
SCHEMBL28910443 0.62 PARG (0.57) PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233845-A1 PARG INHIBITORY COMPOUNDS Cancer Research Technology Limited (GB) 2017-10-25 EP disclosed
WO-2016097749-A1 PARG INHIBITORY COMPOUNDS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-23 WO disclosed